Engaging presentations from mRNA vaccines to how companies are working to meet carbon reduction goals from early on in their projects were key themes of the 2024 ISPE Biotechnology Conference in Boston, MA last week. Read Jeffrey Heil's blog post on his insights here: https://ow.ly/ynBu50SqftV
DPS Group Global’s Post
More Relevant Posts
-
Amindo Biologics: Pioneering Groundbreaking Technology in Biomedicine Discover how Amindo Biologics is leading the way in cutting-edge biotechnology solutions. Visit our website today to learn more about our innovative advancements! #Biomedicine #Innovation #AmindoBiologics #Biotechnology #InnovativeTech #ScienceAdvancements #BiomedicalResearch #BiotechSolutions #CuttingEdgeScience #AmindoBiologics #MedicalInnovation #HealthcareTechnology #BiotechLeadership
To view or add a comment, sign in
-
-
Drug-Linker manufacturing and ADC conjugation facilities require specific regulatory knowledge and an engrained safety culture. They also bring their own unique design, construction and operational challenges. My presentation at INTERPHEX Global has generated some really great conversations about the future of this modality and how we plan to push towards that future. Let's keep the discussion going - what are your biggest challenges when designing and operating these complex facilities? #CRB #ADC #AntibodyDrugConjugate
Since the first antibody drug conjugate (ADC) was approved 24 years ago, the facility design requirements to manufacture these products have gotten more complex and sophisticated. Ashley Harp explained how the technology has evolved and what challenges to address when producing ADCs during her presentation at this year’s INTERPHEX Global Take a look at BioPharm International's feature of her presentation and learn more: https://hubs.la/Q02xk8Hg0 #LifeSciences #Biomanufacturing #Biotech #ADC #AntibodyDrugConjugates
To view or add a comment, sign in
-
-
Click on the link in the post to download you FREE comprehensive report!
We are excited to announce our first publicly available report, we have chosen Vaxart as the target company. Vaxart, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of oral recombinant vaccines administered using temperature-stable tablets that can be stored and shipped without refrigeration, eliminating the need for needle injection. Click the link below to download your FREE comprehensive analysis! https://lnkd.in/gUD2v4nn
To view or add a comment, sign in
-
We are looking forward to be at the 19th annual meeting of the Oligonucleotide Therapeutics Society (OTS) 2023. Our oligo value chain expert Vipul S Rana PhD will be present to meet and discuss with you on the development of your oligonucleotide therapeutics. In addition, he will also guide you on the custom synthesis and Chemistry, Manufacturing & Controls (CMC). So don’t miss such unique opportunity to gain valuable insights. To book your meeting, please write at vrana@innovassynth.com #innovassynth #oligomeeting #oligotherapeutics #oligonucleotide #OTS #ots23 #biotechnology #science #research #biochemistry #medicine #health #biotechnology #barcelona #pharmaceuticals
To view or add a comment, sign in
-
-
With complexity of antibody products on the rise, so are manufacturing costs. That’s just another reason why we are backing VHH antibodies. As single protein domains, complexity is kept to a minimum. This makes is even easier to leverage low-cost manufacturing technologies such as yeast-based systems. In this clip, IP Director Chris Finnis from Phenotypeca shares why VHHs were a great choice for developing their QTL technology, optimising biologics manufacture from baker’s yeast. For the full story behind our Innovate UK funded grant project, read the case study here: https://lnkd.in/eXtfnsSa #VHHantibodies #Biotechnology #Nanobodies #Partnership #antibodies #therapeutics #TheVHHCompany #SME #antibodyproduction #proteinexpression #BIO2024
Chris Finnis talks about why Isogenica's VHHs made a great choice for developing Phenotypeca's yeast manufacturing technology
To view or add a comment, sign in
-
It would be great to learn from Vipul S Rana PhD how Innovassynth can add value to your oligonucleotide therapeutics program.
We are looking forward to be at the 19th annual meeting of the Oligonucleotide Therapeutics Society (OTS) 2023. Our oligo value chain expert Vipul S Rana PhD will be present to meet and discuss with you on the development of your oligonucleotide therapeutics. In addition, he will also guide you on the custom synthesis and Chemistry, Manufacturing & Controls (CMC). So don’t miss such unique opportunity to gain valuable insights. To book your meeting, please write at vrana@innovassynth.com #innovassynth #oligomeeting #oligotherapeutics #oligonucleotide #OTS #ots23 #biotechnology #science #research #biochemistry #medicine #health #biotechnology #barcelona #pharmaceuticals
To view or add a comment, sign in
-
-
Did you know that 90% of disease-causing proteins are undruggable with conventional therapeutics like small molecules and biologics? 🤔 This is in great part due to their flat or featureless protein surfaces which are not amenable to binding by small molecules, or being located inside the cell-membrane making them inaccessible to biologics. Next-generation cyclic peptides have received much attention recently for their ability cross-membranes and bind to featureless sites making them ideal for tackling these difficult targets.✅ What to find out how to exploit this promising drug modality? Talk to us. 👋 #aidrugdiscovery #genai #biotech #drugdiscovery #peptides #hitdiscovery #drugdiscovery #drugdevelopment #peptides #peptidetherapy #cyclicpeptides #macrocycles #artificialintelligence #ai #generativeai #therapeutics #aminoacids #chemicalspace #mentenai #partnering #biotechnology #innovation #machinelearning #ml
To view or add a comment, sign in
-
-
Have you explored the Official Journal of the OTS, the leading journal in its field? The Nucleic Acid Therapeutics journal contains ** Leading-edge research papers and reviews ** Descriptions of emerging technologies ** Commentaries on advancements in oligonucleotide science Explore https://lnkd.in/gfDwMhr to read a free issue! #ots #oligotherapeutics #oligonucleotide #biotech #biotechnology #science #research #pharmaceuticals #networking #otsmember #nucleicacidtherapeutics #nucleicacid #otsjournal
To view or add a comment, sign in
-
-
#Antibodies, #Inhibitors, #Proteins & #Assays for Drug & Therapy Development. We are proud to provide some of the most innovative technologies & #reagents to discover screen & validate drug candidates for discovery & development pipelines 🔗 https://lnkd.in/dA6d38y7 #drugdiscovery #drugtherapy #drugdevelopment #biosciences #lifesciences #no1antibodysupplier #molecularbiology #medicinalchemistry #organicchemistry #research #biopharma #biotech #biochemistry #reagents #pharma #molecule #drugsynthesis #orgchem
To view or add a comment, sign in
-
-
Read your free issue of Nucleic Acid Therapeutics Journal today! ♦️Be prepared to challenge your mind with leading-edge research papers and reviews. ♦️Stay abreast of emerging technologies ♦️Read commentaries on advancements in oligonucleotide science The OTS Official Journal: https://lnkd.in/gfDwMhr #ots #oligotherapeutics #oligonucleotide #biotech #biotechnology #science #research #pharmaceuticals #networking #otsmember #nucleicacidtherapeutics #nucleicacid #otsjournal
To view or add a comment, sign in
-